Atropine and scopolamine – these are plant metabolites with nitrogen-containing ring structures. Both tertiary amines?!
Competitive muscarinic receptor preventing ACh from binding. It is a tertiary amine so blocks both central and peripheral muscarinic receptors.
Eye → mydriasis (dilation of pupil), cycloplegia (paralysis of ciliary muscle of eye)
GI → reduces gastric motility
Urinary system → decreases hypermotility of urinary bladder
CV → bradycardia (low dose), tachycardia (moderate to high dose)
Secretions → decrease salivary sweat and lachrymal [the blockage of sweat glands may cause high body temp]
Low dose → blockade of PRESYNAPTIC M2 (inhibitory) receptors thereby increasing ACh releases which would normally be decreased by binding of ACh to M2 PRESYNAPTIC receptors (inhibiting an inhibitor)
Moderate to High dose → blockade of ATRIAL M2 receptors leading to tachycardia
*High dose of anti-muscarinic agents may cause cutaneous vasodilation = “atropine flush” [unknown mechanism]
Dry mouth, blurred vision, sandy eyes, tachycardia, constipation, CNS effects (restlessness, confusion, hallucinations, delirium, depression, circulatory and respiratory collapse → death)
Scopolamine is a muscarinic antagonist that is used to prevent motion sickness or block short term memory.
These are quarternary ammonium muscarinic antagonist. These drugs are used as inhalational drugs in the treatment of COPD or asthma.
These are tertiary amine muscarinic antagonists. These drugs are used in ophthalmology to produce mydriasis WITH cycloplegia. These drugs are preferred to atropine b/c of shorter duration of action.
These are tertiary amine muscarinic antagonists. They are used to treat Parkinson’s disease and extrapyramidal effects of antipsychotic drugs.
Glycopyrrolate is a muscarinic antagonist that does not cross the blood brain barrier. It is consumed orally to inhibit GI motility or parenterally to prevent bradycardia during surgical procedures.
A muscarinic antagonist used to treat an overactive bladder.
Ganglion blockers (ex. Hexamethonium, mecamylamine, trimethaphan) were originally used for HTN, but due to their adverse side effects they have been replaced by superior antihypertensive agents. Ganglion blockers can block both sympathetic or parasympathetic Nn. Whatever the dominant innervation (ex. cardiac with parasympathetic) is, the opposite will occur when ganglion blockers are used.
2. agonists (depolarizing blockers)
Tubocurarine is a competitive antagonist ,nondepolarizing blocker. It is used as an adjuvant drug in anesthesia during surgery to relax skeletal muscle.
Succinylcholine binds to the nicotinic receptor and depolarizes the junction. It remains in the synaptic cleft continuing to stimulate the receptor thereby desensitizing it. This leads to flaccid paralysis. (activates then inactivates) This drug is used when rapid endotracheal intubation is needed and electroconvulsive therapy (ECT).
Depolarizing agents may cause malignant hyperthermia due to excessive release of calcium from the sarcoplasmic reticulum. Most incidents are due to combination therapy of succinylcholine and an halogenated anesthetic. Treatment for malignant hyperthermia includes Dantrolene which blocks the release of Ca2+ from the SR.
This is an “inhibitor of ACh synthesis” that blocks the CHT (Na+ - choline transporter into the neuron). By blocking the channel it prevents uptake of choline required for ACh synthesis. This drug is not a therapeutic tool but rather just a research, experimental tool
Vesamicol is an ACh storage inhibitor that blocks the ACh-H+ antiporter that is used to transport ACh into vesicles. By blocking the channel it prevents the storage of ACh. This is a research tool and not use therapeutically.